Vanda Pharmaceuticals (VNDA) Earnings Date & Reports

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VNDA is expected to report earnings to fall 58.66% to -20 cents per share on July 24

Vanda Pharmaceuticals VNDA Stock Earnings Reports

Q2'25

Est.

$-0.21

Q1'25

Missed

by $0.48

Q4'24

Beat

by $0.09

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.05

The last earnings report on May 07 showed earnings per share of -50 cents, missing the estimate of -1 cents. With 877.20K shares outstanding, the current market capitalization sits at 232.79M.

View a ticker or compare two or three

Compare

VNDA